These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 567349)

  • 41. Receptors, antireceptor antibodies and mechanisms of insulin resistance.
    Flier JS; Kahn CR; Roth J
    N Engl J Med; 1979 Feb; 300(8):413-9. PubMed ID: 366414
    [No Abstract]   [Full Text] [Related]  

  • 42. [Insulin therapy by subcutaneous infusion using a portable pump. A simple method to stabilize brittle diabetics (author's transl)].
    Berger W; Schwarz U; Kaegi E; Keller U; Viollier E
    Schweiz Rundsch Med Prax; 1979 Dec; 68(49):1620-9. PubMed ID: 397488
    [No Abstract]   [Full Text] [Related]  

  • 43. Medical Grand Rounds. Open and closed loop insulin delivery systems in diabetes: current status.
    Service FJ
    Henry Ford Hosp Med J; 1982; 30(3):163-7. PubMed ID: 6761321
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of continuous subcutaneous insulin infusion pumps--Georgia, Maine, and Nebraska.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1982 Jan; 31(1-2):5-6, 15. PubMed ID: 6798419
    [No Abstract]   [Full Text] [Related]  

  • 45. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program.
    Froesch ER; Blatter G; Morell B
    Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin infusion via a portable pump.
    Orzeck EA
    Tex Med; 1980 Jul; 76(7):46-9. PubMed ID: 6994269
    [No Abstract]   [Full Text] [Related]  

  • 47. [Intensification of conventional insulin therapy of diabetes mellitus].
    Tatoń J; Czech A
    Pol Tyg Lek; 1982 Dec; 37(51-52):1565-70. PubMed ID: 6763989
    [No Abstract]   [Full Text] [Related]  

  • 48. [Maintenance of normoglycemia in diabetics with continuous subcutaneous insulin infusion: a real therapeutical need? (author's transl)].
    Studer PP; Berger W
    Schweiz Rundsch Med Prax; 1981 Jan; 70(5):137-9. PubMed ID: 6782563
    [No Abstract]   [Full Text] [Related]  

  • 49. [Management of decompensated diabetes mellitus using an automatic monitoring and infusion system].
    Berg G; Sailer D
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1787. PubMed ID: 923465
    [No Abstract]   [Full Text] [Related]  

  • 50. Technology of pre-programmable insulin delivery systems: continuous subcutaneous insulin infusion.
    Pickup JC; Keen H; Parsons JA; Alberti KG
    Horm Metab Res Suppl; 1979; (8):49-51. PubMed ID: 395089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Content of growth hormone in the blood in insulin-resistant and insulin-sensitive patients with diabetes mellitus during compensation].
    Alekseeva GG
    Probl Endokrinol (Mosk); 1978; 24(1):3-9. PubMed ID: 634944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison between diabetics receiving a high or low daily insulin dosage.
    Asplin CM; Hartog M; Goldie DJ; Alberti KG; Smythe P; Binder C; Fabero OK
    Horm Metab Res; 1978 Sep; 10(5):365-9. PubMed ID: 568594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insulin antibodies and the control of diabetes.
    Dixon K; Exon PD; Malins JM
    Q J Med; 1975 Oct; 44(176):543-53. PubMed ID: 1105646
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of alpha and beta receptor blockaders on the degree of glycemia, growth hormone content of blood and catecholamine excretion in insulin-dependent diabetes mellitus].
    Alekseeva GG; Iukhlova NA
    Probl Endokrinol (Mosk); 1979; 25(3):13-8. PubMed ID: 37498
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Use of the "Biostator" apparatus in patients with a labile course of diabetes mellitus].
    Spesivtseva BG; Mamaeva GG; Seid-Guseĭnov AA; Turova EA; Leonova LN
    Sov Med; 1983; (2):44-8. PubMed ID: 6344245
    [No Abstract]   [Full Text] [Related]  

  • 56. [The positive inotropic effect of intravenous glucose or insulin-glucose administrations in metabolically healthy probands and in insulin-dependent diabetics].
    Möricke R; Niederstrasser A; Caruso M
    Z Gesamte Inn Med; 1982 Sep; 37(17):545-53. PubMed ID: 6755933
    [No Abstract]   [Full Text] [Related]  

  • 57. [Influence of a nicotinic acid derivative on carbohydrate metabolism in the diabetic patient].
    Judick V; Sachsse B
    Med Klin; 1968 May; 63(18):722-4. PubMed ID: 5719910
    [No Abstract]   [Full Text] [Related]  

  • 58. Normalization of insulin delivery to diabetics by pulsed insulin infusion.
    Martin P; Genuth S
    IEEE Trans Biomed Eng; 1977 Mar; 24(2):116-21. PubMed ID: 892814
    [No Abstract]   [Full Text] [Related]  

  • 59. ["Artificial pancreas" in the treatment of diabetes mellitus].
    Spesivtseva VT; Shumakov VI; Seĭd-Guseĭnov AA; Mamaeva GG; Samoĭlov VD
    Ter Arkh; 1980; 52(12):88-91. PubMed ID: 6787727
    [No Abstract]   [Full Text] [Related]  

  • 60. The perioperative management of diabetes.
    Nel CJ; de Waal JM; Steyn AF
    S Afr J Surg; 1980 Sep; 19(3):107-12. PubMed ID: 7003762
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.